Featured Research

from universities, journals, and other organizations

Swiss And Dutch Health Systems Provide Lessons For US On Achieving Universal Coverage

Date:
January 16, 2009
Source:
Commonwealth Fund
Summary:
A new Commonwealth Fund study says that policies in the Switzerland and Netherlands that achieve near-universal coverage and low administrative costs can help inform the US health-care reform debate. Both countries effectively cover all but one percent of their population -- compared with 15 percent uninsured in the US -- due to an individual mandate to purchase health insurance and premium assistance for those with low incomes.

A new Commonwealth Fund study says that policies in the Switzerland and Netherlands that achieve near-universal coverage and low administrative costs can help inform the U.S. health care reform debate. Both countries effectively cover all but one percent of their population—compared with 15 percent uninsured in the U.S.—due to an individual mandate to purchase health insurance and premium assistance for those with low incomes.

Both countries have also been successful at curbing high administrative costs: the Swiss and Dutch health systems spend about five percent of health care costs on administrative costs, compared with an average of seven percent and even higher rates in private insurance policies in the U.S.

"These countries can serve as idea labs for health reform in the U.S., and we should seek to learn from their successes and failures, just as we learn from the experiences of states like Massachusetts," says Commonwealth Fund President Karen Davis. "There are examples of universal, comprehensive, high-quality, efficient health care systems that can show us the path to high performance."

Both Switzerland and the Netherlands have mixed public-private systems with an individual mandate and insurance market reforms that are similar to the Massachusetts universal coverage law. Both countries' health systems also feature patient choice, broad access to care, and low rates of disparities in care, according to the study, The Swiss and Dutch Health Insurance Systems: Universal Coverage and Regulated Competitive Insurance Markets, by Robert E. Leu of the University of Bern, Switzerland and colleagues.

Key policies that the U.S. might learn from include:

  • Universal coverage attained through a mandate that every individual purchase a basic insurance plan. Both Switzerland and the Netherlands subsidize premiums for low-income households, with about 40 percent of households receiving premium assistance in both countries.
  • National standards for basic coverage for private insurance ensure that benefits are comprehensive for acute care services.
  • Tight regulation of basic health insurance markets, with requirements for open enrollment and community rating, lead to relatively low overhead costs. Administrative and profit-margins account for about 5 percent of premiums.
  • Risk equalization systems help to reduce incentives for insurers to seek healthier enrollees.

While the U.S. spent 15 percent of GDP and $6,700 per capita on health care in 2006, Switzerland spent 11 percent and the Netherlands 9 percent of GDP on health spending; per capita spending was $4,300 in Switzerland and $2,800 in the Netherlands. Both countries achieve better health outcomes compared to the U.S.: in 2005 life expectancy in the U.S. was 77.8 years, compared with 81.4 years in Switzerland and 79.1 years in the Netherlands.

The Commonwealth Fund is a private foundation supporting independent research on health policy reform and a high performance health system.


Story Source:

The above story is based on materials provided by Commonwealth Fund. Note: Materials may be edited for content and length.


Cite This Page:

Commonwealth Fund. "Swiss And Dutch Health Systems Provide Lessons For US On Achieving Universal Coverage." ScienceDaily. ScienceDaily, 16 January 2009. <www.sciencedaily.com/releases/2009/01/090116073154.htm>.
Commonwealth Fund. (2009, January 16). Swiss And Dutch Health Systems Provide Lessons For US On Achieving Universal Coverage. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/01/090116073154.htm
Commonwealth Fund. "Swiss And Dutch Health Systems Provide Lessons For US On Achieving Universal Coverage." ScienceDaily. www.sciencedaily.com/releases/2009/01/090116073154.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins